These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15867492)

  • 1. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
    Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
    AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.
    Massad LS; Schneider MF; Watts DH; Strickler HD; Melnick S; Palefsky J; Anastos K; Levine AM; Minkoff H
    J Womens Health (Larchmt); 2004 Mar; 13(2):147-53. PubMed ID: 15072728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    Swan DC; Tucker RA; Tortolero-Luna G; Mitchell MF; Wideroff L; Unger ER; Nisenbaum RA; Reeves WC; Icenogle JP
    J Clin Microbiol; 1999 Apr; 37(4):1030-4. PubMed ID: 10074522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and typing of human papilloma virus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok.
    Siritantikorn S; Laiwejpithaya S; Siripanyaphinyo U; Auewarakul P; Yenchitsomanus P; Thakernpol K; Wasi C
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):707-10. PubMed ID: 9656389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous evolution of human papillomavirus infection in the uterine cervix.
    Paraskevaidis E; Kalantaridou SN; Georgiou I; Koliopoulos G; Pappa L; Malamou-Mitsi V; Agnantis NJ; Kitchener HC; Lolis DE
    Anticancer Res; 1999; 19(4C):3473-8. PubMed ID: 10629638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.
    Lai HC; Peng MY; Nieh S; Yu CP; Chang CC; Lin YW; Sun CA; Chu TY
    Int J Gynecol Cancer; 2006; 16(2):730-5. PubMed ID: 16681753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears.
    Chua KL; Wiklund F; Lenner P; Angström T; Hallmans G; Bergman F; Sapp M; Schiller J; Wadell G; Hjerpe A; Dillner J
    Int J Cancer; 1996 Sep; 68(1):54-9. PubMed ID: 8895541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.
    Clavel C; Masure M; Levert M; Putaud I; Mangeonjean C; Lorenzato M; Nazeyrollas P; Gabriel R; Quereux C; Birembaut P
    Diagn Mol Pathol; 2000 Sep; 9(3):145-50. PubMed ID: 10976721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
    Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
    Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
    Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
    Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
    JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.